• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性多关节起病型幼年特发性关节炎中骨保护素/核因子κB受体活化因子配体系统失衡:一种骨损伤生物标志物?

Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?

作者信息

Spelling P, Bonfá E, Caparbo V F, Pereira R M R

机构信息

Paediatric Rheumatology Division, Hospital Evangelico de Curitiba, Paraná, Brazil.

出版信息

Scand J Rheumatol. 2008 Nov-Dec;37(6):439-44. doi: 10.1080/03009740802116224.

DOI:10.1080/03009740802116224
PMID:18802807
Abstract

OBJECTIVE

To evaluate the importance of receptor activator of nuclear factor kappaB (RANK)/receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) modulation in active polyarticular juvenile idiopathic arthritis (pJIA) patients with and without bone erosions.

METHODS

Thirty female patients (mean age 11.07+/-3.77 years, range 4-17 years) with active pJIA and 30 healthy gender- and age-matched controls were consecutively selected for this study. All involved articulations were assessed by X-ray and examined for the presence of bone erosions. The serum levels of RANKL and OPG were measured using an enzyme-linked immunosorbent assay (ELISA).

RESULTS

Patients with active pJIA had higher levels of serum RANKL than controls [2.90 (0.1-37.4) vs. 0.25 (0.1-5.7) pg/mL, p = 0.007] and a lower OPG/RANKL ratio [21.25 (1.8-897.6) vs. 347.5 (9-947.8), p = 0.005]. However, levels of OPG were comparable in both groups [55.24 (28.34-89.76) vs. 64.42 (30.68-111.28) pg/mL, p = 0.255]. Higher levels of serum RANKL and a lower OPG/RANKL ratio were also observed in active pJIA patients with bone erosions compared to controls [3.49 (0.1-37.4) vs. 0.25 (0.1-5.7) pg/mL, p = 0.0115 and 14.3 (1.8-897.6) vs. 347.5 (9-947.8), p = 0.016]. However, RANKL levels and OPG/RANKL ratio were similar in pJIA patients without bone erosion and controls [1.75 (0.1-10.9) vs. 0.25 (0.1-5.7) pg/mL, p = 0.055 and 29.2 (3.3-756.8) vs. 347.5 (9-947.8), p = 0.281].

CONCLUSION

These data suggest that active pJIA with bone erosions is associated with high serum levels of RANKL and a low OPG/RANKL ratio, indicating that these alterations may reflect bone damage in this disease.

摘要

目的

评估核因子κB受体激活剂(RANK)/核因子κB配体受体激活剂(RANKL)/骨保护素(OPG)调节在有或无骨侵蚀的活动性多关节型幼年特发性关节炎(pJIA)患者中的重要性。

方法

本研究连续选取了30例活动性pJIA女性患者(平均年龄11.07±3.77岁,范围4 - 17岁)和30例年龄及性别匹配的健康对照。通过X线对所有受累关节进行评估,并检查是否存在骨侵蚀。采用酶联免疫吸附测定(ELISA)法检测血清RANKL和OPG水平。

结果

活动性pJIA患者的血清RANKL水平高于对照组[2.90(0.1 - 37.4)对0.25(0.1 - 5.7)pg/mL,p = 0.007],OPG/RANKL比值低于对照组[21.25(1.8 - 897.6)对347.5(9 - 947.8),p = 0.005]。然而,两组的OPG水平相当[55.24(28.34 - 89.76)对64.42(30.68 - 111.28)pg/mL,p = 0.255]。与对照组相比,有骨侵蚀的活动性pJIA患者血清RANKL水平更高,OPG/RANKL比值更低[3.49(0.1 - 37.4)对0.25(0.1 - 5.7)pg/mL,p = 0.0115;14.3(1.8 - 897.6)对347.5(9 - 947.8),p = 0.016]。然而,无骨侵蚀的pJIA患者与对照组的RANKL水平及OPG/RANKL比值相似[1.75(0.1 - 10.9)对0.25(0.1 - 5.7)pg/mL,p = 0.055;29.2(3.3 - 756.8)对347.5(9 - 947.8),p = 0.281]。

结论

这些数据表明,伴有骨侵蚀的活动性pJIA与血清RANKL水平升高及OPG/RANKL比值降低有关,提示这些改变可能反映了该疾病中的骨损伤。

相似文献

1
Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?活动性多关节起病型幼年特发性关节炎中骨保护素/核因子κB受体活化因子配体系统失衡:一种骨损伤生物标志物?
Scand J Rheumatol. 2008 Nov-Dec;37(6):439-44. doi: 10.1080/03009740802116224.
2
Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?青少年特发性关节炎中的骨保护素(OPG)/核因子κB受体活化因子配体(RANK-L)系统:OPG/RANK-L在骨损伤中是否具有潜在的调节作用?
J Rheumatol. 2004 May;31(5):986-91.
3
RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.未治疗的幼年皮肌炎患儿的核因子κB受体活化因子配体与骨保护素比值及骨密度
Arthritis Rheum. 2007 Mar;56(3):977-83. doi: 10.1002/art.22433.
4
High serum values of soluble CD154, IL-2 receptor, RANKL and osteoprotegerin in Langerhans cell histiocytosis.朗格汉斯细胞组织细胞增多症中可溶性CD154、白细胞介素-2受体、核因子κB受体活化因子配体及骨保护素的血清高值。
Pediatr Blood Cancer. 2006 Aug;47(2):194-9. doi: 10.1002/pbc.20595.
5
Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.慢性酒精性肝病患者血清骨保护素和核因子κB受体活化因子配体水平
Alcohol Alcohol. 2006 May-Jun;41(3):261-6. doi: 10.1093/alcalc/agl004. Epub 2006 Feb 13.
6
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation.肝移植术后早期的骨保护素与核因子-κB受体激活剂配体系统
Clin Transplant. 2006 May-Jun;20(3):383-8. doi: 10.1111/j.1399-0012.2006.00497.x.
7
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.绝经后女性血清核因子-κB 受体活化因子配体、骨保护素、高敏 C 反应蛋白与骨密度之间的关系:骨免疫与骨炎症
Menopause. 2009 Sep-Oct;16(5):950-5. doi: 10.1097/gme.0b013e3181a181b8.
8
Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.异基因造血干细胞移植后骨髓微环境中骨保护素/核因子κB受体活化因子配体比值失衡。
Transplantation. 2006 Dec 15;82(11):1449-56. doi: 10.1097/01.tp.0000244588.42519.72.
9
Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis.慢性肾衰竭及接受透析治疗儿童的骨保护素和核因子κB受体活化因子配体血清水平及其与血清胃饥饿素的关系。
Nephron Clin Pract. 2007;105(4):c153-8. doi: 10.1159/000099005. Epub 2007 Jan 25.
10
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.测量老年女性骨代谢中核因子-κB 受体活化因子配体和骨保护素的可溶性受体的意义
Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22.

引用本文的文献

1
The Evaluation of New-Generation Biomarker sCD14ST Provides New Insight into COVID-19's Effect on Bone Remodeling.新一代生物标志物可溶性CD14亚型(sCD14ST)的评估为新冠病毒病(COVID-19)对骨重塑的影响提供了新见解。
J Clin Med. 2025 Feb 3;14(3):979. doi: 10.3390/jcm14030979.
2
Transcriptomic signatures of classical monocytes reveal pro-inflammatory modules and heterogeneity in polyarticular juvenile idiopathic arthritis.经典单核细胞转录组特征揭示了多关节炎型幼年特发性关节炎中的促炎模块和异质性。
Front Immunol. 2024 May 21;15:1400036. doi: 10.3389/fimmu.2024.1400036. eCollection 2024.
3
Gene association analysis to determine the causal relationship between immune cells and juvenile idiopathic arthritis.
基因关联分析确定免疫细胞与青少年特发性关节炎之间的因果关系。
Pediatr Rheumatol Online J. 2024 Mar 8;22(1):35. doi: 10.1186/s12969-024-00970-8.
4
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.埃及幼年特发性关节炎患儿的骨密度:与血清 RANKL/骨保护素(OPG)比值和 OPG 基因多态性的相关性。
Pediatr Rheumatol Online J. 2023 Jun 16;21(1):58. doi: 10.1186/s12969-023-00843-6.
5
B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?青少年特发性关节炎炎症阶段的B细胞:疾病发病机制中的主角还是配角?
Front Med (Lausanne). 2022 Apr 4;9:851532. doi: 10.3389/fmed.2022.851532. eCollection 2022.
6
Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches.幼年特发性关节炎:从发病机制到治疗方法。
Pediatr Rheumatol Online J. 2021 Aug 23;19(1):135. doi: 10.1186/s12969-021-00629-8.
7
Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis.青少年特发性关节炎高活动度成年患者的血清硬化蛋白
Arthritis Res Ther. 2014 Oct 4;16(5):460. doi: 10.1186/s13075-014-0460-x.
8
Long-term vitamin D3 supplementation does not prevent colonic inflammation or modulate bone health in IL-10 knockout mice at young adulthood.长期补充维生素D3并不能预防年轻成年期白细胞介素-10基因敲除小鼠的结肠炎症或调节其骨骼健康。
Nutrients. 2014 Sep 22;6(9):3847-62. doi: 10.3390/nu6093847.
9
Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis.临床和分子研究结果的相关性分析确定了全身型幼年特发性关节炎的候选生物学途径。
BMC Med. 2012 Oct 23;10:125. doi: 10.1186/1741-7015-10-125.
10
Relationship between serum RANKL and RANKL in bone.血清 RANKL 与骨中 RANKL 的关系。
Osteoporos Int. 2011 Oct;22(10):2597-602. doi: 10.1007/s00198-011-1740-9. Epub 2011 Aug 18.